氨苄西林胎儿与新生儿暴露预测及给药评估的PBPK模型
本研究建立氨苄西林生理药代动力学(PBPK)模型,经成人数据验证后缩放至新生儿和妊娠胎儿。模型预测新生儿和胎儿暴露大多落在90%预测区间内;50 mg/kg q8h方案在>90%虚拟新生儿中达到MIC≤8 mg/L时75% T>MIC目标;孕妇产前1 g氨苄西林可提供分娩前4小时足够胎儿暴露。
要点
- 新生儿氨苄西林50 mg/kg q8h方案对MIC≤8 mg/L可达到75% T>MIC目标。
- 孕妇产前1 g氨苄西林可提供分娩前4小时胎儿暴露>0.25 mg/L。
- PBPK模型整合肾小球滤过、OAT3介导分泌、胆汁排泄及肝代谢。
核心结论
- 所建PBPK模型可表征氨苄西林在新生儿、孕妇和胎儿中的处置,并支持这些脆弱人群的优化给药评估。
研究设计与样本
- 研究采用Simcyp®模拟器先建立成人氨苄西林PBPK模型,再考虑生理参数成熟变化和年龄相关药物处置缩放至新生儿,或扩展为孕妇和胎儿妊娠模型,并用文献浓度数据验证。
主要发现
- 成人模型中89.8%的观测平均浓度在模型平均预测值的2倍范围内。
- 新生儿中78.4%的个体观测值落在90%预测区间内。
- 两项研究中胎儿约65%的个体观测值落在90%预测区间内。
- 50 mg/kg q8h方案在>90%虚拟新生儿中达到MIC≤8 mg/L时75% T>MIC目标。
- 孕妇1 g氨苄西林可提供分娩前4小时胎儿暴露>0.25 mg/L。
关键数值与推荐
- 新生儿推荐方案50 mg/kg每8小时一次,对MIC≤8 mg/L达到75% T>MIC目标。
- 孕妇产前1 g氨苄西林,目标胎儿暴露>0.25 mg/L持续4小时。
临床怎么用
- 临床可参考PBPK模型评估的50 mg/kg q8h方案用于新生儿氨苄西林给药。
- 孕妇产前预防可考虑1 g氨苄西林以覆盖分娩前4小时胎儿暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Ampicillin is frequently used in neonates for the treatment of sepsis and as an intrapartum prophylaxis option for Group B Streptococcus. Pharmacokinetic data to guide ampicillin dosing in neonates and during the intrapartum period are limited. The objective of this study was to build a physiologically-based pharmacokinetic (PBPK) model to characterize the disposition of ampicillin in neonates and foetuses and to inform corresponding optimal dosing regimens. METHODS: An adult ampicillin PBPK model was first developed using the Simcyp® simulator. The adult model was then scaled to neonates by accounting for maturational changes in physiological parameters and age-dependent drug disposition or extended to a pregnancy model for mothers and foetuses. Models were verified using collected mean or individual-level concentration data from the literature. RESULTS: The developed adult PBPK model included elimination via glomerular filtration, OAT3-mediated tubular secretion and biliary excretion as well as hepatic metabolism, and 89.8% of the observed mean concentrations in adults were within a 2-fold range of model mean predictions. Most of the observed individual-level observations in neonates (78.4%) and foetuses (about 65% in two studies) were within the 90% prediction intervals. The recommended 50 mg/kg every 8 h (q8h) ampicillin regimen achieved the 75% fraction time of total drug concentration above minimum inhibitory concentration (T > MIC) target for an MIC ≤8 mg/L in >90% virtual neonates, and 1 g ampicillin for pregnant women provided adequate foetal exposure (>0.25 mg/L) for 4 h prior to delivery. CONCLUSIONS: A PBPK model was developed to characterize ampicillin's disposition in neonates, pregnant women, and foetuses, and the model supported optimal dosing evaluation in these vulnerable populations.
引用
- Li S, Xie F. Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach. Br J Clin Pharmacol. 2022. PMID: 36357171. doi:10.1111/bcp.15589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。